Head to Head Analysis: Wesana Health (OTCMKTS:WSNAF) vs. Veracyte (NASDAQ:VCYT)

Veracyte (NASDAQ:VCYT) and Wesana Health (OTCMKTS:WSNAF) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, valuation, profitability, earnings and risk.

Profitability

This table compares Veracyte and Wesana Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Veracyte	20.37%	9.26%	8.61%
Wesana Health	N/A	N/A	N/A

Valuation and Earnings

This table compares Veracyte and Wesana Health”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Veracyte	$561.90 million	6.20	$66.35 million	$1.41	30.74
Wesana Health	N/A	N/A	N/A	N/A	N/A

Veracyte has higher revenue and earnings than Wesana Health.

Analyst Ratings

This is a summary of current ratings and price targets for Veracyte and Wesana Health, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Veracyte	1	2	6	2	2.82
Wesana Health	0	0	0	0	0.00

Veracyte currently has a consensus target price of $54.33, suggesting a potential upside of 25.37%. Given Veracyte’s stronger consensus rating and higher probable upside, analysts clearly believe Veracyte is more favorable than Wesana Health.

Summary

Veracyte beats Wesana Health on 8 of the 8 factors compared between the two stocks.

About Veracyte

Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm’s portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA.

About Wesana Health

Wesana Health Holdings Inc. does not have significant operations. Previously, it was developing evidence-based formulations and protocols that empower patients to overcome neurological, psychological, and mental health ailments caused by trauma. The company is headquartered in Chicago, Illinois.